This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025. But what is driving this surge in healthcare ad spend? How does AI impact pharma marketing?
As we approach 2025, emerging trends are reshaping how the industry engages with patients and healthcareproviders. With advancements in technology, increasing competition, and changing patient expectations, pharma marketers need to stay ahead of the curve. Patient-Centric Marketing Patients want to feel heard.
Introduction: In 2025, programmatic advertising will continue to redefine how pharmaceutical brands reach healthcareproviders (HCPs) and patients. In this article, well explore key programmatic trends for 2025 and how they can help your campaigns become more targeted, efficient, and compliant.
To stay competitive, teams must reframe their approach to brand storytelling, targeting, and value delivery. Key Trends Disrupting Healthcare Marketing To stay ahead, pharma marketers must recognize the industry trends reshaping the field. What skills should pharma marketing teams develop in 2025?
Imagine launching a brand campaign without guessworkwhere your message reaches the right healthcare professional at the right time on the right channel. Thats the promise of data-driven marketing , a strategy thats rapidly transforming how pharmaceutical companies approach promotion, education, and engagement in 2025.
The world of pharma marketing is changing rapidly, and 2025 will be no exception. From digital transformation and personalized marketing to compliance and competition, the upcoming years will demand flexibility and innovative thinking. So, what will be the top challenges in 2025, and how can pharma marketers tackle them?
AI Is No Longer Just Theory This shift is already happening, with the fastest-moving companies embedding AI into three critical areas: Sales & Marketing Execution AI is helping sales teams identify the right healthcareproviders, personalize marketing messages, and optimize engagement in real time. Scaling AI: What Needs to Change?
In 2025, pharma marketing news is filled with innovation, disruption, and opportunities to grow your business. Whether it’s leveraging new digital tools or understanding regulatory shifts, keeping pace is key to staying competitive. What are the biggest challenges in pharma marketing in 2025?
AI assists in analyzing patterns, while omnichannel strategies ensure that content reaches healthcareproviders (HCPs) and patients at the most impactful moments. Rather than relying on broad outreach, marketers can now use data-driven insights to identify the right audience and craft messages that resonate.
In an increasingly competitive pharmaceutical landscape, the significance of healthcare branding has never been more pronounced. As we approach 2025, the ability of pharmaceutical companies to effectively craft and communicate their brand identity will play a pivotal role in determining their market success.
The medical device industry has long been a globalized ecosystem, with raw materials, components, and finished products crisscrossing international supply chains before reaching healthcareproviders. Additionally, international markets may become more competitive for U.S. However, the latest wave of U.S.
As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. Data-driven strategies enable pharma marketers to identify patterns and predict future trends, allowing them to stay ahead of the competition.
Applying AI to GVDs Amassing comprehensive productand market-related data, GVDs demonstrate the value of a pharmaceutical product to various stakeholders, including payers, healthcareproviders, and regulatory bodies.
During the COVID-19 pandemic, we saw healthcare organizations spend and scramble to implement numerous virtual care point solutions. The global healthcare IT market was valued at $280.3 billion by 2025, growing at a compound annual growth rate of 6.7%. billion in 2020 and is expected to reach $381.7 fitness trackers).
Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. If you have to wait to extract meaning from your data then you won’t be competitive enough. “A
These high prices are the result of multiple factors: theyre derived from living organisms making them sensitive and complex for both manufacturers and patients, research requires advanced technology to test for safety and effectiveness, and theyre in high demand without much competition. 19, 2025 [link] 5. 2024 [link] 4. Alira Health.
billion by 2025. Moreover, we’ll shed light on the evolution of medical sales techniques and strategies, the impact of technology, and the importance of talent acquisition to thrive in this competitive domain. They serve as the primary link between healthcareproviders and cutting-edge medical solutions.
Lacking this fundamental understanding as a sales rep can negatively impact a providers interest in a new product and their business relationship with the company. [1] 1] How can mastering pharmacology give sales reps a competitive advantage when meeting with prospective HCPs? Accessed January 7, 2025. References: 1.
This guide explores essential strategies to ensure your team is prepared for the shifting dynamics of healthcare marketing in 2025 and beyond. New digital tools, regulatory adjustments, and emerging consumer trends constantly reshape the way healthcare brands engage with their audiences.
After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.
In the pharmaceutical sector, this evolved further with privacycompliant data enrichment, enabling hyper-personalized messaging for healthcareproviders (HCPs). By tracking preferences and behaviors, companies tailored interactions to make them more meaningful and effective.
In todays rapidly evolving landscape, executives must navigate a complex mix of innovation, regulation, and competition to remain relevant. Because the way your company communicates its value to patients, healthcareproviders, and stakeholders can mean the difference between success and failure. Why does this matter?
With these launches came more complex science, which pushed biopharma’s evolution to integrate more medical engagement alongside the existing commercial focus for healthcareproviders and payers. Pricing regulations have already been rolled out in Japan, and Europe plans to introduce a single health technology assessment (HTA) in 2025.
As we enter 2025, one thing remains clear: marketing has evolved beyond simply promoting services. With my years of experience navigating this fast-paced industry, I believe next year will be pivotal and demand that healthcare organizations position themselves for long-term growth.
By the end of 2025, video content is expected to account for 82% of all internet traffic (bandwidth). Is your healthcare organization leading the way with this trend or is your content getting lost in the noise? Trust, clarity, and connection are essential in the healthcare industry, making video a strategic imperative.
The rapid growth in investment and adoption of AI in healthcare in 2024 brings a new wave of legal and regulatory developments. As we kick off 2025, those deploying AI in healthcare must be cognizant of new compliance requirements under federal and state law. Two are noteworthy from a healthcare perspective.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content